Can scan findings predict colorectal cancer spread?
Part of Cancer, Digestive system clinical trials.
This study looks at whether signs of blood vessel involvement (called EMVI) seen on scans can predict if colorectal cancer spreads to other organs. You might join if you already had surgery to remove the cancer from the colon or rectum and any distant tumors, and your before-surgery scans are available for review.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older and have colorectal cancer.
- Your colon or rectum with the cancer has been removed during surgery.
- You have also had surgery to remove any cancer that spread to other parts of your body (like the liver or lungs).
- You had a CT or MRI scan before your surgery that is available for the study team to review.
- Your primary tumor did not completely disappear after treatment (no complete response).
- You have enough tissue from your surgery to study in the lab.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of CT scan (spectral CT) to see how well it detects colorectal cancer that has spread to the liver or belly lining. It may help doctors better plan surgery to remove all the cancer.
This study looks at a blood test that detects cancer DNA (ctDNA) and compares it with CT scan findings before surgery. It may help doctors understand how aggressive the cancer is and how scan features relate to blood test results.
This study checks whether a special MRI scan (DW-MRI) can spot liver metastases early in people with high-risk colorectal cancer. Finding metastases sooner may help doctors choose the right treatment path.
This study looks at how well cancer found on scans matches the actual cancer seen under the microscope after surgery. It may help improve how doctors plan treatment for colon, sigmoid, or rectal adenocarcinoma.
This study looks for biological markers that can help predict where colorectal cancer might spread. It aims to find patterns that could guide future treatment decisions. By understanding these markers, doctors may be able to detect and manage cancer recurrence earlier.
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
Hear when a new Colo-rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.